Research Article

An effective approach for botulinum toxin injection in patients with stroke for focal spasticity: dual guidance

Volume: 5 Number: 9 September 30, 2018
EN

An effective approach for botulinum toxin injection in patients with stroke for focal spasticity: dual guidance

Abstract

Objective: This study has aimed to compare the efficacy of botulinum toxin (BTX) injections, applied to the upper limb muscles of the stroke patients in our clinic who have being diagnosed with focal spasticity, that are performed via ultrasonography and ultrasonography + electrical muscle (EM) stimulator guidance. Literature didn’t include detailed crosscheck of ultrasound guided BTX and EM treatment applications for upper limb focal spasticity patients

Materials and Methods: Electronic data on 62 hemiplegic stroke patients with grade 2 and 3 focal spasticity who had received botulinum toxin injections into their upper limb muscles by the same physician, who used similar protocol and recorded the results, were scanned retrospectively. The spasticity of the patients in both groups was assessed with the Modified Ashworth Scale at the end of two weeks and three months.

Results: A statistically significant difference was found between the Modified Ashworth Scale values of both groups in terms of all muscles, compared to the values seen in the pre-treatment period (p<0.05). The Modified Ashworth Scale values at 3 months posttreatment in ultrasonography + electrical muscle stimulator group were not statistically different from those at 2 weeks posttreatment, with respect to wrist flexion and finger flexion. In intergroup comparison, there was no statistically significant difference between the Modified Ashworth Scale values of at pretreatment and 2 weeks posttreatment. However, statistically significant difference in all muscle groups was found in favor of the ultrasonography + electrical muscle stimulator group at 3 months posttreatment controls (p<0.05).

Conclusion: Upper limb spasticity due to stroke can be substantially recovered with botulinum toxin injections that are applied via only ultrasonography guidance or via ultrasonography + electrical muscle stimulator guidance.. According to data from the assessment at 3 months posttreatment, the botulinum toxin injection performed via ultrasonography + electrical muscle stimulator guidance had more positive effects .

Keywords

References

  1. 1. Yersal O. Clinical outcome of patients with glioblastoma multiforme: 1. Hankey GJ, Stroke. How large a public health problem and how can the neurologist help? Arch Neurol. 1999;56(6):748-54.
  2. 2. Ozcakir S, Sivrioglu K. Botulinum Toxin in Poststroke Spasticity, Clin Med Res. 2007;5(2):132-8.
  3. 3. Thompson AJ, Jarrett L, Lockley L, Marsden J, Stevenson VL. Clinical management of spasticity. J Neurol Neurosurg Psychiatry. 2005;76(4):459-63.
  4. 4. Karataş GK. Bölüm 168, İnme, Fiziksel Tıp ve Rehabilitasyon, 2. Baskı. (Ed: Beyazova M, Kutsal YG), Güneş Tıp Kitabevleri. 2011; 2761-88.
  5. 5. Simpson D.M. Clinical trials of botulinum toxin in the treatment of spasticity: Etiology, Evaluation, Management and the Role of Botulinum Toxin, chapter 10. 2002; 125-30.
  6. 6. Çeliker R. Bölüm 58, Spastisite Tedavisinde Kullanılan İlaçlar, Fiziksel Tıp ve Rehabilitasyon, 2. Baskı, (Ed: Beyazova M, Kutsal YG), Güneş Tıp Kitabevleri. 2011; 901-17.
  7. 7. Picelli A, Lobba D, Midiri A, Prandi P, Melotti C, Baldessarelli S,et al. Botulinum toxin injection into the forearm muscles for wrist and fingers spastic overactivity in adults with chronic stroke: a randomized controlled trial comparing three inject. Clin Rehabil. 2014;28(3):232-42.
  8. 8. Chin TY, Nattrass GR, Selber P, Graham HK. Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy: a comparison between manual needle placement and placement guided by electrical stimulation. J Pediatr Orthop. 2005;25(3):286-91.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Authors

Murat Kosem This is me
Türkiye

Publication Date

September 30, 2018

Submission Date

September 15, 2018

Acceptance Date

September 20, 2018

Published in Issue

Year 2018 Volume: 5 Number: 9

APA
Ata, E., & Kosem, M. (2018). An effective approach for botulinum toxin injection in patients with stroke for focal spasticity: dual guidance. Medical Science and Discovery, 5(9), 326-330. https://doi.org/10.17546/msd.460182
AMA
1.Ata E, Kosem M. An effective approach for botulinum toxin injection in patients with stroke for focal spasticity: dual guidance. Med Sci Discov. 2018;5(9):326-330. doi:10.17546/msd.460182
Chicago
Ata, Emre, and Murat Kosem. 2018. “An Effective Approach for Botulinum Toxin Injection in Patients With Stroke for Focal Spasticity: Dual Guidance”. Medical Science and Discovery 5 (9): 326-30. https://doi.org/10.17546/msd.460182.
EndNote
Ata E, Kosem M (September 1, 2018) An effective approach for botulinum toxin injection in patients with stroke for focal spasticity: dual guidance. Medical Science and Discovery 5 9 326–330.
IEEE
[1]E. Ata and M. Kosem, “An effective approach for botulinum toxin injection in patients with stroke for focal spasticity: dual guidance”, Med Sci Discov, vol. 5, no. 9, pp. 326–330, Sept. 2018, doi: 10.17546/msd.460182.
ISNAD
Ata, Emre - Kosem, Murat. “An Effective Approach for Botulinum Toxin Injection in Patients With Stroke for Focal Spasticity: Dual Guidance”. Medical Science and Discovery 5/9 (September 1, 2018): 326-330. https://doi.org/10.17546/msd.460182.
JAMA
1.Ata E, Kosem M. An effective approach for botulinum toxin injection in patients with stroke for focal spasticity: dual guidance. Med Sci Discov. 2018;5:326–330.
MLA
Ata, Emre, and Murat Kosem. “An Effective Approach for Botulinum Toxin Injection in Patients With Stroke for Focal Spasticity: Dual Guidance”. Medical Science and Discovery, vol. 5, no. 9, Sept. 2018, pp. 326-30, doi:10.17546/msd.460182.
Vancouver
1.Emre Ata, Murat Kosem. An effective approach for botulinum toxin injection in patients with stroke for focal spasticity: dual guidance. Med Sci Discov. 2018 Sep. 1;5(9):326-30. doi:10.17546/msd.460182